Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5172 of 6351
-
Experimental combo therapy for advanced cancer shows early promise but trial cut short
Disease control Stopped earlyThe main purpose is to assess the safety and clinical activity of GEN1042 in combination with radiotherapy or GEN1042 in combination with radiotherapy and pembrolizumab as a treatment option for participants with metastatic solid tumors.
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New rinse may ease root canal pain better than standard
Symptom relief CompletedThis single-centre, randomized, parallel-group clinical trial compared two commonly used final irrigants in single-visit root canal treatment: octenidine dihydrochloride (OCT) and chlorhexidine (CHX). Adults with single-rooted, single-canal teeth diagnosed with asymptomatic apica…
Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated Jun 26, 2026 16:59 UTC
-
Can better training boost HPV shots? study tests two methods
Prevention CompletedThis trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert. Other clinics will receive the same training from a vac…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Liver Function's impact on experimental brain drug tested
Knowledge-focused CompletedThis study is open to people with and without liver problems. People can join the study if they are 18 to 79 years of age and have a body mass index (BMI) between 18.5 and 35 kg/m2. Iclepertin (also called BI 425809) is a medicine that is being developed to treat diseases of the…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a smart shirt replace a heart catheter?
Knowledge-focused Stopped earlyThe Nanowear SimpleSense study is a single center, prospective, non-randomized, feasibility, non- significant risk study The study will be done in 2 phases. Phase 1 will use SimpleSense data collected from the first set of subjects and associate the data from SimpleSense to the r…
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Heart attack recovery: do women and men get equal prevention care?
Knowledge-focused CompletedPARTICIPANT CENTERS: 25 hospitals managing routinely acute myocardial infarction (AMI) and representing different regions from Spain will be invited to participate. GENERAL OBJECTIVE: To evaluate if there are differences in the level of adherence to recommended secondary prevent…
Sponsor: Spanish Society of Cardiology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
App-Based learning may cut heart risk after attack
Knowledge-focused CompletedThe purpose of this study was to demonstrate the impact of digital education on the cardiovascular risk factors in post-Myocardial Infarction patients and to generate evidence for broad implementation of the proposed education program.
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Experimental cancer combo tested in tiny, terminated trial
Disease control Stopped earlyThis is a Phase Ib, two-part, multi-center study. In Part 1, the study will evaluate the safety and tolerability, antitumor activity, pharmacokinetics, and determine the maximum tolerated dose (MTD) of 2X-121 monotherapy (at BID regimen) in patients with advanced solid tumors. In…
Phase 1 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can relaxation techniques beat workplace stress? hospital trial halted early
Symptom relief Stopped earlyWork stress and psychosocial risks are a major public health problem. Health-care workers (HCW) are particularly at risk. Moreover, non-HCW staff of hospitals can also be at risk, with working environment described as the main risk factor. The University Hospital (CHU) of Clermon…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New hypertension drug shows promise in early safety trial
Disease control CompletedThis is a randomized, double-blind, placebo-controlled study including Part A single ascending dose (SAD) in healthy subjects and Part B single dose in subjects with mild hypertension.
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Video Game-Like grip trainer boosts fistula health in kidney patients
Disease control CompletedIsometric exercise can effectively promote the vascular function of arteriovenous fistula and increase hand grip strength, but patients needs to perform isometric exercises patiently. The purpose of this study want investigate the effect of using individual intelligent devices fo…
Sponsor: National Taipei University of Nursing and Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Simple memory test could spot dementia early
Knowledge-focused Recruiting nowIn this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. This tes…
Sponsor: Centre Hospitalier de Lens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New dosing method may better prevent infections in overweight surgery patients
Disease control CompletedThe goal of this clinical study is to compare the dosing of an antibiotic in overweight patients having surgery. The main question\[s\] it aims to answer are: * Are the antibiotic concentrations in blood and fat tissue in patients that are overweight sufficient to prevent the ch…
Phase 4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AR training helps med students deliver better simulated births
Knowledge-focused CompletedThis study evaluated whether an augmented reality (AR)-based training system improves preparation for simulated vaginal birth compared with traditional text- and video-based learning. Vaginal birth is a complex clinical skill that requires integration of technical actions, situat…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Can a vegan diet help manage Early-Stage leukemia?
Disease control CompletedThis study will evaluate the feasibility of an 8-week vegan whole-food, plant-based dietary intervention in subjects with low risk CLL who are undergoing observation. Over the course of 8 weeks, participants will attend weekly group cooking classes via Zoom lead by a RD. Particip…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Diet plan may help fight muscle weakness in liver cirrhosis
Disease control CompletedLiver cirrhosis can lead to weakness, frailty, and poor quality of life, even in patients whose disease is still in a relatively stable phase. Many people with cirrhosis have low muscle strength and frailty, but these problems often go unrecognised and untreated. This study is te…
Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Apple watch and health coaching aim to ease caregiver burden
Symptom relief CompletedThe Self-care for Dementia Caregivers Study is a behavioral health intervention that uses digital monitoring tools and motivational health coaching to help caregivers of persons with dementia engage in a regular routine of sleep and activity. Participants wear an apple watch for …
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a bone drug help women with myeloma? small study launches
Disease control OngoingThe purpose of this study is to measure the effect of romosozumab on bone formation and breakdown (resorption) and determine if romosozumab is a safe treatment for osteoporosis and myeloma-related bone disease (MBD) in postmenopausal people with multiple myeloma (MM).
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a game replace genetic counseling for prenatal screening?
Knowledge-focused CompletedAdvancements in prenatal genetic screening have significantly improved the identification of chromosomal abnormalities and heritable conditions during pregnancy, yet current standards for patient education in this domain are largely ineffective. The most effective approach to edu…
Sponsor: Erin Rothwell • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could ditching gowns and gloves for this superbug be safe in elderly wards?
Knowledge-focused Recruiting nowThis is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of e…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC